Downloadable Slidesets

Share

Program Content

Activities

  • Advances in FL
    New Advances in Follicular Lymphoma
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 15, 2021

    Expires: December 14, 2022

  • Advances in MZL and MCL
    What’s New in Marginal Zone Lymphoma and Mantle Cell Lymphoma?
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2021

    Expires: December 15, 2022

  • Advances in DLBCL
    New Advances in Diffuse Large B-Cell Lymphoma
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2021

    Expires: December 15, 2022

  • EBV-Associated PTLD
    Novel Approaches to the Treatment of EBV-Associated Post-Transplant Lymphoproliferative Disorders
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2021

    Expires: December 15, 2022

  • <i>EP</i>: Advances in B-Cell Lymphomas
    ExpressPoints: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 04, 2022

Faculty

cover img faculity

Brad S. Kahl, MD

Skoronski Chair of Lymphoma Research
Associate Director for Clinical Research
UW Carbone Cancer Center
University of Wisconsin School of Public Health
Madison, Wisconsin

cover img faculity

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

cover img faculity

Julie M. Vose, MD

Neumann M. and Mildred E. Harris Professor
Chief
, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Atara Biotherapeutics

Bayer Healthcare Pharma

BeiGene, Ltd.

Epizyme

Genentech, a member of the Roche Group

Genmab US, Inc.

Incyte Corporation

Karyopharm Therapeutics

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc